Skip to main content
Premium Trial:

Request an Annual Quote

Tempus: Joel Dudley

Joel Dudley has joined Tempus as senior vice president of research, in charge of all non-oncology R&D efforts for the company, which is in the midst of expanding from its original focus on cancer into cardiology and depression. Dudley previously was executive VP for precision health at Mount Sinai Health System and founding director of the Institute for Next Generation Healthcare at the Icahn School of Medicine at Mount Sinai. 

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.